Nature Search

Transforming jet flavour tagging at ATLAS

Identifying jets originating from heavy quarks plays a fundamental role in hadronic collider experiments. In this work, the ATLAS Collaboration describes and tests a transformer-based neural network architecture for jet flavour tagging based on low-level input and physics-inspired constraints.

G. Aad
E. Aakvaag
L. Zwalinski
ResearchOpen Access14 Jan 2026
Nature Communications

Volume: 17, P: 1-22
Cosmic quadrupole?

Richard A. Muller
News & Views25 Jun 1981
Nature

Volume: 291, P: 609-610
History of the Mediterranean salinity crisis

Kenneth J. Hsü
Lucien Montadert
Ramil Wright
Research02 Jun 1977
Nature

Volume: 267, P: 399-403
Determination of the spin and parity of all-charm tetraquarks

The CMS Collaboration reports the measurement of the spin, parity, and charge conjugation properties of all-charm tetraquarks, exotic fleeting particles formed in proton–proton collisions at the Large Hadron Collider.

A. Hayrapetyan
V. Makarenko
A. Snigirev
ResearchOpen Access03 Dec 2025
Nature

Volume: 648, P: 58-63
Mapping the genetic landscape across 14 psychiatric disorders

Genomic analyses applied to 14 childhood- and adult-onset psychiatric disorders identifies five underlying genomic factors that explain the majority of the genetic variance of the individual disorders.

Andrew D. Grotzinger
Josefin Werme
Jordan W. Smoller
ResearchOpen Access10 Dec 2025
Nature

Volume: 649, P: 406-415
Elliptic anisotropy measurement of the f₀(980) hadron in proton-lead collisions and evidence for its quark-antiquark composition

The quark structure of the f₀(980) hadron is still unknown after 50 years of its discovery. Here, the CMS Collaboration reports a measurement of the elliptic flow of the f₀(980) state in proton-lead collisions at a nucleon-nucleon centre-of-mass energy of 8.16 TeV, providing strong evidence that the state is an ordinary meson.

A. Hayrapetyan
A. Tumasyan
A. Zhokin
ResearchOpen Access27 Aug 2025
Nature Communications

Volume: 16, P: 1-19
Polygenic score analyses on antidepressant response in late-life depression, results from the IRL-GRey study

Samar S. M. Elsheikh
Victoria S. Marshe
Daniel J. Müller
Reviews22 Nov 2024
The Pharmacogenomics Journal

Volume: 24, P: 1-7
MicroRNAs and other non-coding RNAs as targets for anticancer drug development

Non-coding RNAs (ncRNAs) are involved in the development of a number of diseases, including cancer, and the first ncRNA-targeted therapeutics have recently entered clinical trials. Here, Calin, Ling and Fabbri present the latest insights into ncRNA biology, with a focus on microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), and discuss how these inform therapeutic strategies that modulate ncRNAs in cancer.

Hui Ling
Muller Fabbri
George A. Calin
Reviews31 Oct 2013
Nature Reviews Drug Discovery

Volume: 12, P: 847-865
Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs

T-UCRs encode long non-coding RNAs implicated in human carcinogenesis, but the underlying mechanisms are poorly understood. Here, the authors identify uc.339 as an oncogene in lung cancer that is upregulated through the loss of TP53 and promotes Cyclin E activation by entrapping regulatory miRNAs.

Ivan Vannini
Petra M. Wise
Muller Fabbri
ResearchOpen Access27 Nov 2017
Nature Communications

Volume: 8, P: 1-19
Observation of quantum entanglement with top quarks at the ATLAS detector

Entanglement was observed in top–antitop quark events by the ATLAS experiment produced at the Large Hadron Collider at CERN using a proton–proton collision dataset with a centre-of-mass energy of √s = 13 TeV and an integrated luminosity of 140 fb⁻¹.

G. Aad
B. Abbott
L. Zwalinski
ResearchOpen Access18 Sept 2024
Nature

Volume: 633, P: 542-547
A portrait of the Higgs boson by the CMS experiment ten years after the discovery

The most up-to-date combination of results on the properties of the Higgs boson is reported, which indicate that its properties are consistent with the standard model predictions, within the precision achieved to date.

A. Tumasyan
W. Adam
A. Zhokin
ResearchOpen Access04 Jul 2022
Nature

Volume: 607, P: 60-68
Measurement of the Higgs boson width and evidence of its off-shell contributions to ZZ production

The CMS Collaboration reports evidence for off-shell Higgs boson contributions in the production of Z boson pairs, and measures the width of the Higgs boson, which is inversely related to its lifetime.

A. Tumasyan
W. Adam
W. Vetens
ResearchOpen Access20 Oct 2022
Nature Physics

Volume: 18, P: 1329-1334
Observation of triple J/ψ meson production in proton-proton collisions

The CMS Collaboration reports the study of three simultaneous hard interactions between quarks and gluons in proton–proton collisions. This manifests through the concurrent production of three J/ψ mesons, which consist of a charm-quark–antiquark pair.

A. Tumasyan
W. Adam
W. Vetens
ResearchOpen Access19 Jan 2023
Nature Physics

Volume: 19, P: 338-350
A detailed map of Higgs boson interactions by the ATLAS experiment ten years after the discovery

Ten years after the discovery of the Higgs boson, the ATLAS experiment at CERN probes its kinematic properties with a significantly larger dataset from 2015–2018 and provides further insights on its interaction with other known particles.

G. Aad
B. Abbott
L. Zwalinski
ResearchOpen Access04 Jul 2022
Nature

Volume: 607, P: 52-59
Observation of the rare B_s⁰ →µ⁺µ⁻ decay from the combined analysis of CMS and LHCb data

Combined analysis of proton-proton collision data from the Large Hadron Collider at CERN by the CMS and LHCb collaborations leads to the observation of the extremely rare decay of the strange B meson into muons; the result is compatible with the standard model of particle physics, and does not show any signs of new physics, such as supersymmetry.

V. Khachatryan
A.M. Sirunyan
E. Pesen
ResearchOpen Access13 May 2015
Nature

Volume: 522, P: 68-72
Publisher Correction: Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs

Ivan Vannini
Petra M. Wise
Muller Fabbri
Amendments and CorrectionsOpen Access08 Jan 2018
Nature Communications

Volume: 9, P: 1
Measurement of the inelastic proton–proton cross-section at √s=7 TeV with the ATLAS detector

The measurement of the total cross-section of proton–proton collisions is of fundamental importance for particle physics. Here, the first measurement of the inelastic cross-section is presented for proton–proton collisions at an energy of 7 teraelectronvolts using the ATLAS detector at the Large Hadron Collider.

G. Aad
B. Abbott
L. Zwalinski
ResearchOpen Access06 Sept 2011
Nature Communications

Volume: 2, P: 1-14
Ptychoscopy: a user friendly experimental design tool for ptychography

Radim Skoupy
Elisabeth Müller
Emiliya Poghosyan
ResearchOpen Access10 Jul 2025
Scientific Reports

Volume: 15, P: 1-15
Exploring representations of human grasping in neural, muscle and kinematic signals

Andreea I. Sburlea
Gernot R. Müller-Putz
ResearchOpen Access12 Nov 2018
Scientific Reports

Volume: 8, P: 1-14
Predicting opioid consumption after surgical discharge: a multinational derivation and validation study using a foundation model

Chris Varghese
Luke Peters
Caroline Reinke
ResearchOpen Access26 Aug 2025
npj Digital Medicine

Volume: 8, P: 1-16
Author Correction: A detailed map of Higgs boson interactions by the ATLAS experiment ten years after the discovery

G. Aad
B. Abbott
L. Zwalinski
Amendments and CorrectionsOpen Access18 Oct 2023
Nature

Volume: 623, P: E5
Author Correction: A portrait of the Higgs boson by the CMS experiment ten years after the discovery

A. Tumasyan
W. Adam
A. Zhokin
Amendments and CorrectionsOpen Access18 Oct 2023
Nature

Volume: 623, P: E4
Publisher Correction: Observation of triple J/ψ meson production in proton-proton collisions

A. Tumasyan
W. Adam
W. Vetens
Amendments and CorrectionsOpen Access12 Dec 2023
Nature Physics

Volume: 20, P: 332
Noncoding RNA therapeutics — challenges and potential solutions

Over the past decade, several RNA-based therapies have gained FDA approval. Additional noncoding RNA (ncRNA)-based therapeutic approaches — targeting microRNAs and long ncRNAs — are now also gaining interest. Here, Calin and co-authors assess the hurdles facing the clinical translation of ncRNA-based therapeutics and highlight promising emerging solutions to address these issues.

Melanie Winkle
Sherien M. El-Daly
George A. Calin
Reviews18 Jun 2021
Nature Reviews Drug Discovery

Volume: 20, P: 629-651
Publisher Correction: Observation of triple J/ψ meson production in proton-proton collisions

A. Tumasyan
W. Adam
W. Vetens
Amendments and CorrectionsOpen Access27 Feb 2023
Nature Physics

Volume: 19, P: 461
Cellular and viral microRNAs in sepsis: mechanisms of action and clinical applications

Dana Elena Giza
Enrique Fuentes-Mattei
George Adrian Calin
Reviews14 Oct 2016
Cell Death & Differentiation

Volume: 23, P: 1906-1918

Search

Filter By:

Search

Quick links